"Asked by Axios' Peter Sullivan if he'd vote for Trump's plan, Welch said he would "not only vote for it, I would work actively and aggressively to make it happen." He noted that Trump hasn't introduced any legislation yet and he'd like the president to "do it, not just talk about it.""
"The most-favored nation deals Trump has made with at least 16 pharmaceutical companies are designed to lower costs, but the terms of the deals are not public, leading some Democrats to allege they may benefit big pharma more than Americans."
"Welch and Sen. Josh Hawley (R-Mo.) are already working together on a bipartisan bill that would bar drugmakers from charging Americans more than the international average price. When Welch unveiled the plan in early May, he said the bill offers the Trump administration a Congressional "template" to make that goal a reality."
A proposal aims to align American drug prices with what other developed nations pay. Support includes active work to make the plan happen, with a request for concrete action rather than talk. Existing most-favored nation deals with at least 16 pharmaceutical companies are intended to lower costs, but deal terms are not public, raising concerns that benefits may favor big pharma. Welch and Sen. Josh Hawley are working on a bipartisan bill that would bar drugmakers from charging Americans more than the international average price. The bill is presented as a Congressional template for enabling the Trump administration to implement the goal.
#drug-pricing #most-favored-nation #bipartisan-legislation #pharmaceutical-companies #international-price-index
Read at Axios
Unable to calculate read time
Collection
[
|
...
]